ATE481133T1 - Mittel zum senken des blutglukosespiegels - Google Patents

Mittel zum senken des blutglukosespiegels

Info

Publication number
ATE481133T1
ATE481133T1 AT03738666T AT03738666T ATE481133T1 AT E481133 T1 ATE481133 T1 AT E481133T1 AT 03738666 T AT03738666 T AT 03738666T AT 03738666 T AT03738666 T AT 03738666T AT E481133 T1 ATE481133 T1 AT E481133T1
Authority
AT
Austria
Prior art keywords
blood glucose
ghs
antagonist
agents
glucose levels
Prior art date
Application number
AT03738666T
Other languages
English (en)
Inventor
Akio Inui
Akihiro Asakawa
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE481133T1 publication Critical patent/ATE481133T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Mirrors, Picture Frames, Photograph Stands, And Related Fastening Devices (AREA)
  • External Artificial Organs (AREA)
AT03738666T 2002-07-05 2003-07-03 Mittel zum senken des blutglukosespiegels ATE481133T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002197582 2002-07-05
PCT/JP2003/008482 WO2004004772A1 (ja) 2002-07-05 2003-07-03 糖尿病治療剤

Publications (1)

Publication Number Publication Date
ATE481133T1 true ATE481133T1 (de) 2010-10-15

Family

ID=30112403

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03738666T ATE481133T1 (de) 2002-07-05 2003-07-03 Mittel zum senken des blutglukosespiegels

Country Status (15)

Country Link
US (1) US20060276381A1 (de)
EP (1) EP1541171B1 (de)
JP (1) JP5113320B2 (de)
KR (1) KR20050039829A (de)
CN (1) CN1681532A (de)
AT (1) ATE481133T1 (de)
AU (1) AU2003246261A1 (de)
BR (1) BR0312463A (de)
CA (1) CA2493906A1 (de)
DE (1) DE60334225D1 (de)
ES (1) ES2351856T3 (de)
MX (1) MXPA05000160A (de)
PL (1) PL374481A1 (de)
RU (1) RU2005102923A (de)
WO (1) WO2004004772A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4843827B2 (ja) * 2005-02-23 2011-12-21 国立大学法人京都大学 膵臓β細胞の再生促進剤及び膵臓β細胞におけるインスリン産生促進剤
EP2021015A2 (de) 2006-04-28 2009-02-11 The Administrators Of The Tulane Educational Fund Ghrelin/ghrp/ghsr-antagonisten und ihre verwendung
KR20090119785A (ko) 2007-03-12 2009-11-19 유키지루시 뉴교 가부시키가이샤 성장 호르몬 분비 촉진제
CN101951937A (zh) * 2007-12-21 2011-01-19 赫尔辛医疗股份公司 使用伊帕瑞林刺激胃肠系统动力的方法
WO2010022213A2 (en) * 2008-08-22 2010-02-25 Elixir Pharmaceuticals, Inc. Compositions and methods for preserving pancreatic islet mass
US9724381B2 (en) 2009-05-12 2017-08-08 The Administrators Of The Tulane Educational Fund Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
CN102639700A (zh) 2009-09-30 2012-08-15 哈佛大学校长及研究员协会 通过调节自噬增强基因产物调节自噬的方法
US20110105389A1 (en) 2009-10-30 2011-05-05 Hoveyda Hamid R Macrocyclic Ghrelin Receptor Antagonists and Inverse Agonists and Methods of Using the Same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010020012A1 (en) * 2000-02-01 2001-09-06 Andersen Maibritt Bansholm Use of compounds for the regulation of food intake
AU2001228325A1 (en) * 2000-02-01 2001-08-14 Novo-Nordisk A/S Use of compounds for the regulation of food intake
EP1286697A2 (de) * 2000-05-17 2003-03-05 Eli Lilly And Company Methode zur selektiven hemmung der aktivität von ghrelin
CA2411667A1 (en) * 2000-05-30 2001-12-06 Merck & Co. Inc. Ghrelin analogs
JP4493913B2 (ja) * 2001-01-31 2010-06-30 中外製薬株式会社 低栄養症状疾患治療剤
US6949261B2 (en) * 2002-11-12 2005-09-27 Ayurvedic-Life International, Llc Compositions for diabetes treatment and prophylaxis

Also Published As

Publication number Publication date
US20060276381A1 (en) 2006-12-07
MXPA05000160A (es) 2006-02-28
KR20050039829A (ko) 2005-04-29
EP1541171A1 (de) 2005-06-15
JPWO2004004772A1 (ja) 2005-11-04
WO2004004772A1 (ja) 2004-01-15
PL374481A1 (en) 2005-10-31
DE60334225D1 (de) 2010-10-28
CA2493906A1 (en) 2004-01-15
ES2351856T3 (es) 2011-02-11
CN1681532A (zh) 2005-10-12
EP1541171A4 (de) 2008-04-09
EP1541171B1 (de) 2010-09-15
BR0312463A (pt) 2005-04-26
AU2003246261A1 (en) 2004-01-23
RU2005102923A (ru) 2005-10-10
JP5113320B2 (ja) 2013-01-09

Similar Documents

Publication Publication Date Title
NO20060908L (no) Substituerte tazol-benzoisotiazoldioksidderivater, deres fremstilling og anvendelse
NO20051165L (no) Benzotiazolderivater som har -adrenoerseptorantagonist aktivitet
SI1845095T1 (sl) Derivati 1 - tio - D - glukitola
HUP0303876A3 (en) Preparation of pharmaceutical compositions for treatment of type 2 diabetes using piperidine or tiazolidine, inhibitors of dipeptidyl peptidase iv
NO20065926L (no) Substituerte oksazolbenzoisotiazoldioksidderivater samt fremgangsmate for fremstilling og anvendelse derav
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20051871L (no) Opioidreseptorantagonister
TNSN06315A1 (en) Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful the treatment of type 2 diabetes
NO20082445L (no) Neuropeptid-2 reseptor-agonister
DE602004009905D1 (de) 6-substituierte nikotinamidderivate als opioidrezeptorantagonisten
NO20072389L (no) Substituerte benzokinolizinderivater
GB0201508D0 (en) Organic compounds
NO20081844L (no) Terapeutiske forbindelser
WO2003082260A3 (en) Tuberculosis treatment using pleuromutilin derivatives
NO20083036L (no) Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av depresjon
NO20073830L (no) Medikamenter for behandling eller forebygging av fibrotiske sykdommer
DK1675591T3 (da) Farmaceutisk sammensætning omfattende en monoamin-neurotransmitter-genoptagelseshæmmer og en acetylcholinesterase-hæmmer
MA28706B1 (fr) Antagoniste des recepteurs du glucagon, preparation et utilisations therapeutiques
DE60302157D1 (de) Opioidrezeptorantagonisten
UA84896C2 (ru) Производные гидронопола как агонисты человеческих рецепторов orl1
DK1614419T3 (da) Midler til forebyggelse/behandling af retinale nervesygdomme, indeholdende alkyletherderivater eller salte deraf
DE60334225D1 (de) Mittel zum senken des blutglukosespiegels
DK1926729T3 (da) Benzothiazolcyclobutylaminderivater og deres anvendelse som histamin-3-receptorligander
NO20070974L (no) Substituerte N-acyl-2-aminotiazoler
WO2004024066A3 (en) Method of treating diabetes and related conditions

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties